The RFC4 mRNA expression levels in CC tissues at clinical stages I, II, III, and IV were significantly higher than those in normal tissues adjacent to the cancer (P < 0.001); however, no statistically significant difference was observed among the four stages (P > 0.05) (Figure 4C). Here, RFC4 is linked to cancer.